These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20626616)

  • 1. WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A.
    Booth CJ; Brooks MB; Rockwell S; Murphy JW; Rinder HM; Zelterman D; Paidas MJ; Compton SR; Marks PW
    J Thromb Haemost; 2010 Nov; 8(11):2472-7. PubMed ID: 20626616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.
    Radic CP; Rossetti LC; Abelleyro MM; Tetzlaff T; Candela M; Neme D; Sciuccati G; Bonduel M; Medina-Acosta E; Larripa IB; de Tezanos Pinto M; De Brasi CD
    J Thromb Haemost; 2015 Apr; 13(4):530-9. PubMed ID: 25611311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII.
    Cai XH; Wang XF; Dai J; Fang Y; Ding QL; Xie F; Wang HL
    J Thromb Haemost; 2006 Sep; 4(9):1969-74. PubMed ID: 16805874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.
    Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ
    Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution.
    Guillet B; Lambert T; d'Oiron R; Proulle V; Plantier JL; Rafowicz A; Peynet J; Costa JM; Bendelac L; Laurian Y; Lavergne JM
    Hum Mutat; 2006 Jul; 27(7):676-85. PubMed ID: 16786531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
    Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C
    Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of seven novel mutations in the factor VIII gene in 18 unrelated Chinese patients with hemophilia A.
    Hua BL; Yan ZY; Liang Y; Yan M; Fan LK; Li KX; Xiao B; Liu JZ; Zhao YQ
    Chin Med J (Engl); 2010 Feb; 123(3):305-10. PubMed ID: 20193250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel F8 -/- rat as a translational model of human hemophilia A.
    Nielsen LN; Wiinberg B; Häger M; Holmberg HL; Hansen JJ; Roepstorff K; Tranholm M
    J Thromb Haemost; 2014 Aug; 12(8):1274-82. PubMed ID: 24931420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
    Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
    Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to recombinant human coagulation factor VIII in a new rat model of severe hemophilia A.
    Lövgren KM; Søndergaard H; Skov S; Weldingh KN; Tranholm M; Wiinberg B
    J Thromb Haemost; 2016 Apr; 14(4):747-56. PubMed ID: 26784374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations.
    Elmahmoudi H; Khodjet-el-khil H; Wigren E; Jlizi A; Zahra K; Pellechia D; Vinciguerra C; Meddeb B; Elggaaied AB; Gouider E
    Diagn Pathol; 2012 Aug; 7():93. PubMed ID: 22883072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
    Rode F; Almholt K; Petersen M; Kreilgaard M; Kjalke M; Karpf DM; Groth AV; Johansen PB; Larsen LF; Loftager M; Haaning J
    J Thromb Haemost; 2018 Jun; 16(6):1141-1152. PubMed ID: 29582559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A.
    Hemşinlioğlu C; Aslan ES; Taştan C; Çakırsoy D; Turan RD; Seyis U; Elek M; Sır Karakuş G; Günaydın ÖS; Abanuz S; Kançağı DD; Yurtsever B; Yalçın K; Kasap M; Ovalı E
    Turk J Haematol; 2023 May; 40(2):118-124. PubMed ID: 37022209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.
    Strålfors A; Mikovic D; Schmidt D; Onelöv L; Soutari NMH; Berndtson M; Chaireti R; Holmström M; Antovic JP; Bruzelius M
    Thromb Haemost; 2021 Jan; 121(1):27-35. PubMed ID: 32791533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel splicing mutation in F8 causes various aberrant transcripts in a hemophilia A patient and identifies a new transcript from healthy individuals.
    Yi S; Zuo Y; Yu Q; Yang Q; Li M; Lan Y; Huang L; Zhang Q; Qin Z; Luo J
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):506-510. PubMed ID: 32852327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.